Live Breaking News & Updates on China National Medical Products Association

Stay updated with breaking news from China national medical products association. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Iruplinalkib Improves PFS Vs Crizotinib in Locally Advanced or Metastatic ALK+ NSCLC

Treatment with iruplinalkib significantly improved progression-free survival and produced a higher objective response rate compared with crizotinib in patients with ALK TKI–naïve, locally advanced and metastatic ALK-positive non–small cell lung cancer, according to data from a prespecified interim analysis of the phase 3 INSPIRE trial. ....

Runxiang Yang , China National Medical Products Association , Second Medical Oncology Department , Yunnan Cancer Hospital , National Medical Products Association , Lung Cancer , Non Small Cell Lung Cancer , Brain Metastases , Iruplinalkib , Alk Nsclc ,